Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

Focused chemists in lab coats and safety goggles making experiments.

Residual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated with neoadjuvant chemotherapy (NAC) had a higher score of a biomarker of distant metastatic recurrence than tumors from white patients, according to data presented at the 2022 San Antonio Breast Cancer Symposium, held December 6-10, 2022.

Meta’s Oversight Board comes out swinging against Facebook’s VIP ‘cross-check’ program

Previous article

Itchy eyes and a runny nose? It could be climate change

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations